Richardson T M, Stryjewski B L, Broder C C, Hoxie J A, Mascola J R, Earl P L, Doms R W
Department of Pathology, University of Pennsylvania, Philadelphia 19104, USA.
J Virol. 1996 Feb;70(2):753-62. doi: 10.1128/JVI.70.2.753-762.1996.
The humoral immune response to human immunodeficiency virus type 1 (HIV-1) is often studied by using monomeric or denatured envelope proteins (Env). However, native HIV-1 Env complexes that maintain quaternary structure elicit immune responses that are qualitatively distinct from those seen with monomeric or denatured Env. To more accurately assess the levels and types of antibodies elicited by HIV-1 infection, we developed an antigen capture enzyme-linked immunosorbent assay using a soluble, oligomeric form of HIV-1IIIB Env (gp140) that contains gp120 and the gp41 ectodomain. The gp140, captured by various monoclonal antibodies (MAbs), retained its native oligomeric structure: it bound CD4 and was recognized by MAbs to conformational epitopes in gp120 and gp41, including oligomer-specific epitopes in gp41. We compared the reactivities of clade B and clade E serum samples to captured Env preparations and found that while both reacted equally well with oligomeric gp140, clade B seras reacted more strongly with monomeric gp120 than did clade E samples. However, these differences were minimized when gp120 was captured by a V3 loop MAb, which may lead to increased exposure of the CD4 binding site. We also measured the ability of serum samples to block binding of MAbs to epitopes in gp120 and gp41. Clade B serum samples consistently blocked binding of oligomer-dependent MAbs to gp41 and, to a slightly lesser extent, MAbs to the CD4 binding site in gp120. Clade E serum samples showed equivalent or greater blocking of oligomer-dependent gp41 antibodies and considerably less blocking of CD4-binding-site MAbs. Finally, we found that < 5% of the antibodies in clade B sera bound to epitopes present only in monomeric gp120, 30% bound to epitopes present in both monomeric gp120 and oligomeric gp140, and 70% bound to epitopes present in oligomeric gp140, which includes gp41. Thus, captured oligomeric Env closely reflects the antigenic characteristics of Env protein on the surface of virions and infected cells, retains highly conserved epitopes that are recognized by antibodies raised against different clades, and makes it possible to detect a much greater fraction of total anti-HIV-1 Env activity in sera than does native monomeric gp120.
对人类免疫缺陷病毒1型(HIV-1)的体液免疫反应通常通过使用单体或变性包膜蛋白(Env)来研究。然而,维持四级结构的天然HIV-1 Env复合物引发的免疫反应在性质上与单体或变性Env引发的免疫反应不同。为了更准确地评估HIV-1感染引发的抗体水平和类型,我们开发了一种抗原捕获酶联免疫吸附测定法,使用一种可溶性的、寡聚形式的HIV-1IIIB Env(gp140),其包含gp120和gp41胞外结构域。被各种单克隆抗体(MAb)捕获的gp140保留了其天然寡聚结构:它结合CD4,并被针对gp120和gp41中构象表位的MAb识别,包括gp41中的寡聚体特异性表位。我们比较了B亚型和E亚型血清样本与捕获的Env制剂的反应性,发现虽然两者与寡聚gp140的反应同样良好,但B亚型血清与单体gp120的反应比E亚型样本更强。然而,当gp120被V3环MAb捕获时,这些差异被最小化,这可能导致CD4结合位点的暴露增加。我们还测量了血清样本阻断MAb与gp120和gp41中表位结合的能力。B亚型血清样本始终能阻断依赖寡聚体的MAb与gp41的结合,并在稍小程度上阻断与gp120中CD4结合位点的MAb的结合。E亚型血清样本对依赖寡聚体的gp41抗体的阻断作用相当或更强,而对CD4结合位点MAb的阻断作用则明显较弱。最后,我们发现B亚型血清中<5%的抗体与仅存在于单体gp120中的表位结合,30%与单体gp120和寡聚gp140中都存在的表位结合,70%与寡聚gp140中存在的表位结合,其中包括gp41。因此,捕获的寡聚Env紧密反映了病毒体和感染细胞表面Env蛋白的抗原特性,保留了被针对不同亚型产生的抗体识别的高度保守表位,并且与天然单体gp120相比,能够检测出血清中更大比例的总抗HIV-1 Env活性。